Zionexa

New York, United States Founded: 2018 • Age: 8 yrs Acquired By GE Healthcare
Molecular imaging platforms for oncology diagnostics are developed by Zionexa.
Request Access

About Zionexa

Zionexa is a company based in New York (United States) founded in 2018 was acquired by GE Healthcare in May 2021.. Zionexa operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $5.73 M (USD), Debt – Conventional

    Dec 01, 2018

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    GE Healthcare

    (May 06, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Zionexa
Headcount 10-50
Employee Profiles 5
Employee Profiles
People
Peter Webner
CEO, US
People
Jerome Francillard
CFO
People
Jean-Bernard Deloye
Head of Access
People
Yann Bouvet
CSO

Unlock access to complete

Funding Insights of Zionexa

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $5.7M
  • First Round

    (01 Dec 2018)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2018 Amount Debt – Conventional - Zionexa Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Zionexa

Zionexa has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Healthcare and JEREMIE Auvergne. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Financial support is provided for SMEs and startups in Auvergne.
Founded Year Domain Location
Materials management solutions are provided for healthcare organizations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Zionexa

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Zionexa

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zionexa Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Zionexa

Zionexa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zionexa

Frequently Asked Questions about Zionexa

When was Zionexa founded?

Zionexa was founded in 2018.

Where is Zionexa located?

Zionexa is headquartered in New York, United States. It is registered at New York, New York, United States.

What does Zionexa do?

Zionexa was established in 2018 in New York, United States, as a spin-off from Cyclopharma in the oncology sector. Molecular imaging platforms and companion diagnostics for targeted therapies are developed by the company. PET scans incorporating biomarkers are provided to support oncologists in personalizing treatments for various cancers. The pipeline encompasses LBT999 and ZMK in phases 2 and 3, along with ESTROTEP at the filing stage for breast cancer.

Who are the top competitors of Zionexa?

Zionexa's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.

Who are Zionexa's investors?

Zionexa has 2 investors. Key investors include GE Healthcare, and JEREMIE Auvergne.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available